Century Therapeutics, Inc.
Company Information
Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Emerging growth company
State of Incorporation DE
Business Address 25 N 38TH STREET, 11TH FLOOR, PHILADELPHIA, PA, 19104
Mailing Address 25 N 38TH STREET, 11TH FLOOR, PHILADELPHIA, PA, 19104
Phone 215-981-4000
Fiscal Year End 1231
EIN 842040295
Financial Overview
FY2024
-$126.57M
Net Income
$360.69M
Total Assets
$-1.61
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| S-3 Shelf registration for future offerings | February 5, 2026 | View on SEC |
| 4 Insider stock transaction report | February 5, 2026 | View on SEC |
| 4 Insider stock transaction report | February 4, 2026 | View on SEC |
| 4 Insider stock transaction report | February 4, 2026 | View on SEC |
| 4 Insider stock transaction report | February 4, 2026 | View on SEC |
| 4 Insider stock transaction report | February 4, 2026 | View on SEC |
| 8-K Current report of material events | January 23, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | January 16, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | January 16, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | January 16, 2026 | View on SEC |
Material Events
8-K Strategy Change January 23, 2026
High Impact
- Avoided reverse stock split, signaling renewed investor confidence and organic stock price recovery.
- Regained Nasdaq compliance, removing the immediate threat of delisting.
Insider Trading
BUY 4 insiders
8 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2836)
INTENSITY THERAPEUTICS, INC.
INTS Biological Products, (No Diagnostic Substances)
AMGEN INC
AMGN Biological Products, (No Diagnostic Substances)
Vitro Biopharma, Inc.
Biological Products, (No Diagnostic Substances)
Twist Bioscience Corp
TWST Biological Products, (No Diagnostic Substances)
Surrozen, Inc./DE
SRZN Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.